List of Oncology Medication For

Blood Disorders

Hematologic diseases are disorders which primarily affect the blood and blood-forming organs. Hematologic diseases include rare genetic disorders, anemia, HIV, sickle cell disease and complications from chemotherapy or transfusions.

If Blood Disorders Medicines are not yet approved or available in your area, you may give a request, to get access price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj).

Decitabine and Cedazuridine Tablets

Leukemia

decitabine and cedazuridine tablets,
for oral use Initial U.S. Approval: 2020

Inqovi (decitabine and cedazuridine) is a medication used for the treatment of adults with myelodysplastic syndromes (MDS), including chronic myelomonocytic leukemia (CMML).

Facts about decitabine and cedazuridine tablets

Disease Indications-Leukemia
Manufacturer-Astex Pharmaceuticals
Usage-Intravenous
Medicine Approved By-Food and Drug Administration (FDA), Health Canada
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “decitabine and cedazuridine tablets” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Denosumab Injection

Bone Cancer, Bone marrow

denosumab injection
for subcutaneous use Initial U.S. Approval: 2010

denosumab injection is a RANK ligand (RANKL) inhibitor indicated for: • Prevention of skeletal-related events in patients with bone metastases from solid tumors • Treatment of adults and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where surgical resection is likely to result in severe morbidity.

Facts about denosumab injection

Approval Date: 1970
Proprietary Name: On Request
Active Ingredient(s): denosumab injection
Dosage Forms And Strengths: 120 mg/1.7 mL (70 mg/mL) single-use vial
Manufacturer: Amgen Inc.
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “denosumab injection” based on the information you provide.

Doxorubicin Injection

Bone Cancer, Bone marrow

doxorubicin Injection
SP For Intravenous Use Only

Facts about Doxorubicin Injection

Approval Date: 1991
Proprietary Name: On Request
Active Ingredient(s): Doxorubicin Injection
Dosage Forms And Strengths:
Manufacturer:
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Doxorubicin Injection” based on the information you provide.

Duvelisib Capsules

Leukemia, Lymphoma

duvelisib capsules
for oral use Initial U.S. Approval: 2018

Copiktra (duvelisib) is a medication used for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and follicular lymphoma (FL) after at least two prior therapies.

Facts about duvelisib capsules

Disease Indications-Leukemia, Lymphoma
Manufacturer-Verastem Inc.
Usage-Oral
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Duvelisib Capsules” based on the information you provide.

Elotuzumab for injection

Multiple Myeloma

elotuzumab for injection
for intravenous use Initial U.S. Approval: 2015

Empliciti (elotuzumab) is a medication, used in combination with lenalidomide and dexamethasone, for the treatment of multiple myeloma in patients who have received one to three prior therapies.

Facts about elotuzumab Intravenous infusion

DISEASE INDICATIONS-Multiple Myeloma
MANUFACTURER-Bristol-Myers Squibb
USAGE- 1 vial of powder for infusion of 300 mg
MEDICINE APPROVED BY-European Medical Agency (EMA),Food and Drug Administration (FDA),Therapeutic Goods administration (TGA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “elotuzumab for injection” based on the information you provide.

glasdegib tablets

Leukemia

glasdegib tablets
for oral use Initial U.S. Approval: 2018

Daurismo (glasdegib) is a prescription medicine that is used with the medicine cytarabine to treat adults with newly-diagnosed acute myeloid leukaemia (AML).

Facts about glasdegib tablets

DISEASE INDICATIONS-Leukemia
MANUFACTURER-Pfizer, Inc
USAGE-Tablets: 100 mg, 25 mg.
MEDICINE APPROVED BY-European Medical Agency (EMA),Food and Drug Administration (FDA),Health Canada
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “sotorasib tablets” based on the information you provide.

Human Albumin Baxalta Solution for Infusion

Blood Disorders

HUMAN ALBUMIN BAXALTA 200 g/l Solution for Infusion

Human albumin is used to restore and maintain blood volume in patients who have lost blood or fluid due to certain medical conditions.

Facts about Human Albumin Baxalta

Proprietary Name: On Request
Active Ingredient(s): Human Albumin Baxalta
Dosage Forms And Strengths: A vial of 100 ml contains 20 g of human albumin
Current indications: blood or fluid due to certain medical conditions.
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Human Albumin Baxalta” based on the information you provide.

hydroxyurea capsules

Leukemia, Head And Neck

hydroxyurea capsules
for oral use Initial U.S. Approval: 1967

hydroxyurea capsules is an antimetabolite indicated for the treatment of: • Resistant chronic myeloid leukemia. • Locally advanced squamous cell carcinomas of the head and neck, (excluding lip) in combination with concurrent chemoradiation.

Facts about hydroxyurea capsules

Approval Date: 1967
Proprietary Name: On Request
Active Ingredient(s): hydroxyurea capsules
Dosage Forms And Strengths: Capsules: 500 mg
Company: Bristol-Myers Squibb
Current indications: chronic myeloid leukemia, head and neck
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import hydroxyurea capsules” based on the information you provide.

Ibrutinib Capsules

Leukemia

ibrutinib capsules
for oral use Initial U.S. Approval: 2013

Facts about ibrutinib capsules

Approval Date: 2013
Proprietary Name: On Request
Active Ingredient(s): Ibrutinib
Dosage Forms And Strengths: Capsules: 70 mg and 140 mg
Tablets: 140 mg, 280 mg, 420 mg, and 560 mg
Oral suspension: 70 mg/mL
Companies: AbbVie, Johnson & Johnson
Diseases: Imbruvica is indicated for chronic lymphocytic leukemia (CLL), chronic lymphocytic leukemia (CLL) with 17p deletion, Waldenström’s macroglobulinemia (WM) and mantle cell lymphoma (MCL) who have received at least one prior treatment
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “ibrutinib capsules” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

IDHIFA (enasidenib) Tablets

Leukemia

Generic Name: (enasidenib). Brand Name: IDHIFA.
IDHIFA (enasidenib) Tablets is used to treat acute myeloid leukemia (AML).

IDHIFA is an isocitrate dehydrogenase-2 inhibitor indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation as detected by an FDA approved test.

Brand Name:	IDHIFA
Generic Name:	enasidenib
Strength:	• Tablets: 50 mg or 100 mg
Manufacturer:	Celgene Corporation
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “IDHIFA (enasidenib) Tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Blood Disorders

decitabine and cedazuridine tablets, for oral use Initial U.S. Approval: 2020

Access the best support services globally

denosumab injection for subcutaneous use Initial U.S. Approval: 2010

Facts about denosumab injection

Access the best support services globally

doxorubicin Injection SP For Intravenous Use Only

Facts about Doxorubicin Injection

Access the best support services globally

duvelisib capsules for oral use Initial U.S. Approval: 2018

Facts about duvelisib capsules

Access the best support services globally

elotuzumab for injection for intravenous use Initial U.S. Approval: 2015

Facts about elotuzumab Intravenous infusion

Access the best support services globally

glasdegib tablets for oral use Initial U.S. Approval: 2018

Facts about glasdegib tablets

Access the best support services globally

HUMAN ALBUMIN BAXALTA 200 g/l Solution for Infusion

Facts about Human Albumin Baxalta

Access the best support services globally

hydroxyurea capsules for oral use Initial U.S. Approval: 1967

Facts about hydroxyurea capsules

Access the best support services globally

ibrutinib capsules for oral use Initial U.S. Approval: 2013

Facts about ibrutinib capsules

Access the best support services globally

Generic Name: (enasidenib). Brand Name: IDHIFA. IDHIFA (enasidenib) Tablets is used to treat acute myeloid leukemia (AML).

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

decitabine and cedazuridine tablets,
for oral use Initial U.S. Approval: 2020

denosumab injection
for subcutaneous use Initial U.S. Approval: 2010

doxorubicin Injection
SP For Intravenous Use Only

duvelisib capsules
for oral use Initial U.S. Approval: 2018

elotuzumab for injection
for intravenous use Initial U.S. Approval: 2015

glasdegib tablets
for oral use Initial U.S. Approval: 2018

hydroxyurea capsules
for oral use Initial U.S. Approval: 1967

ibrutinib capsules
for oral use Initial U.S. Approval: 2013

Generic Name: (enasidenib). Brand Name: IDHIFA.
IDHIFA (enasidenib) Tablets is used to treat acute myeloid leukemia (AML).